Jun Xu

Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma

Bo Zhai, Fengli Hu, Xian Jiang et al. · Molecular Cancer Therapeutics · 2014 · 283 citations

Medicine, Oncology, Pharmacology +17

Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells

Jiejie Dong, Bo Zhai, Weihua Sun et al. · PLoS ONE · 2017 · 110 citations · Full text

Medicine, Cancer Biology, Pharmacology +17

Soy isoflavonoids and cancer — metabolism at the target site

Brenda J. Boersma, Stephen Barnes, Martyn Kirk et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 2001 · 53 citations

Medicine, Oncology, Pharmacology +14

RETRACTED: Overexpressed lncRNA GATA6-AS1 Inhibits LNM and EMT via FZD4 through the Wnt/β-Catenin Signaling Pathway in GC

Zhengtian Li, Xu Zhang, Dawei Wang et al. · Molecular Therapy — Nucleic Acids · 2019 · 48 citations · Full text

Medicine, Cell Biology, Oncology +17

Immune signature profiling identified prognostic factors for gastric cancer

Wenhui Yang, Zhiyong Lai, Yuan Li et al. · Chinese Journal of Cancer Research · 2019 · 44 citations · Full text

Medicine, Immunology, Oncology +17